26 February 2020

For many types of cancer, surgical resection is the best or only chance for cure. Incomplete excision of tumor tissue however, negatively affects the prognosis of the patient. In many cases, the presence of (microscopic) residual tumor tissue at the resection margins is a direct predictor of patient survival.

The completeness of tumor removal during surgery is dependent on the surgeon’s ability to differentiate tumor from normal tissue. Ideally, surgeons could use real-time information to detect tumors or positive resection margins during surgery. To accomplish radical excision of tumor tissue, radiotracers can be used that target tumor tissue and can be detected using a gamma probe during surgery. Yet, this technique cannot provide a precise delineation of the tumor and resection margins. The addition of a fluorescent label could help to overcome this limitation. Intraoperative fluorescence imaging could allow accurate real-time tumor delineation, but the penetration depth of emitted light in biological tissue is limited. So, a powerful synergy can be achieved by combining radiotracers for the detection of tumor tissue, and fluorescent tracers for subsequent accurate delineation of tumors.

Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic. For example, in patients with renal cell carcinoma, intraoperative dual-modality imaging is applied using girentuximab labeled with 111In and IRDye800CW. Similarly, in patients with peritoneal metastases of colorectal cancer we have started a study on radiodetection and fluorescence imaging during surgical resection.
The initial results show that both radionuclide detection and fluorescence imaging provide useful information to improve localization of tumors and radical excision of tumor tissue.

Related news items

The ICI Amsterdam-Leiden-Nijmegen cancer vaccine consortium

7 April 2020

The Chemical Immunology group from Martijn Verdoes, theme Nanomedicine, joined forces with two Organic Chemistry groups and a Chemical Biology group from Leiden University, and Immunology groups at the AmsterdamUMC and the LUMC to form a consortium to develop new cancer vaccines.

read more

Martinus van Marum prize for Tom Schirris

3 April 2020

This award of € 12,500 is intended as an incentive prize for researchers who have obtained their PhD degree in 2015 or later. The jury, consisting of members of the Society, came to this decision unanimously.

read more

Crowdfunding for research and innovations

3 April 2020

Radboud university medical center and Radboud University collaborate on initiatives in the fight against corona.

read more

New scientific integrity contact Bart Kiemeney

2 April 2020

Bart Kiemeney will replace Gerhard Zielhuis as one of the contact persons scientific integrity.

read more

Extended deadlines grant proposals

31 March 2020

The deadlines to submit grant proposals has been extended by most funding agencies.

read more

HFSP Grant for Johannes Textor

30 March 2020

Johannes Textor, theme Cancer development and immune defense, has been awarded a program grant of 1 million US dollars by The Human Frontier Science Program (HFSP) to investigate how T cells navigate extremely dense environments using experiments, modeling and methods from pedestrian dynamics.

read more